Dr. Eric Costanzo, DO

Dr. Costanzo practices at Shore Pulmonary, PA in Manasquan, New Jersey.

Dr. Costanzo's NPI, 1700977923, was assigned on September 27, 2006. Dr. Costanzo graduated from Rowan-Virtua School of Osteopathic Medicine - Stratford in 2001. Dr. Costanzo holds New Jersey license 25MB07782000.

Dr. Costanzo's primary practice is Shore Pulmonary, PA, at 2640 Hwy 70, Manasquan, NJ 08736 in Monmouth County. The practice phone is (732) 528-5900.

Dr. Costanzo's primary practice is Shore Pulmonary, PA in Manasquan, New Jersey. Dr. Costanzo is also affiliated with Jersey Shore University Medical Center. The medical group on file is Shore Pulmonary, P.A. Dmand AI also links Dr. Costanzo to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Costanzo practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Costanzo's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Costanzo is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Costanzo is licensed in New Jersey.

Dmand AI lists asthma, bronchitis, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, hypersomnia, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Costanzo treats.

CMS data shows 1,868 Medicare services from Dr. Costanzo across 14 procedure codes in 2024, for 822 Medicare patients. Medicare paid $169,114 for them.

CMS counts 822 Medicare patients who saw Dr. Costanzo in 2024. The largest group is 75 to 84, with 317 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Costanzo's median patient age at 71, with 47% women.

In 2024, Dr. Costanzo wrote 608 Medicare Part D claims for 149 patients. 48% of them were for generic drugs. CMS names the drug for 399 of them, across 14 drugs with 11 or more claims each, at $1,037,453 in total drug cost. In 2023, CMS named 127 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Costanzo for performance year 2024, reported as part of a group. Dr. Costanzo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Costanzo, published from 2017 to 2024. 2020 was the busiest year, with 8. The most frequent topics are Renal Dialysis, Catheterization, Central Venous and Kidney Failure, Chronic. Dr. Costanzo has published most often in Cureus. Dr. Costanzo's most frequent co-authors are Tushar Jitendra Vachharajani, MD, Avais Masud, MD and Usman Mazahir, MD.

CMS Open Payments shows 350 general payments to Dr. Costanzo from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $800.

Dmand AI lists 1 award for Dr. Costanzo, most recently CMS Stage 1 EHR in 2013.

Dr. Costanzo graduated from Rowan-Virtua School of Osteopathic Medicine - Stratford in 2001. Dr. Costanzo is a member of AOA.

Dr. Costanzo is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.